Alphion India Launches Small Form Factor GPON Optical Line Terminal Platform

Alphion® India Private Limited announced today the launch of the AOLT-4200, small-form factor, Optical Line Terminal (OLT) platform that specifically addresses rural broadband and mobile backhaul applications. Alphion® India is exhibiting its full range of GPON products at the India Telecom 2012 exhibition, in New Delhi, India, December 13th – 15th.

“The AOLT-4200 platform was developed at our Research and Design centers in Mumbai and Chennai to meet the unique requirements of the rural broadband environment and is being locally manufactured by our partner in Sriperumbudir, Tamil Nadu” commented Dr. Bharat P. Dave, Chairman and Managing Director of Alphion® India. “The platform also includes the critical timing features needed for wireless mobile backhaul. The ability to efficiently backhaul large amounts of data through GPON based access networks solves a major constraint for today’s and future wireless networks. The AOLT-4200 addresses the bottlenecks and inefficiencies created in wireless backhaul networks as broadband access becomes dominant in base station backhaul and the size of the wireless cells decreases.”

Alphion® India GPON solutions enable the convergence of wireless and wire-line networks as it is suitable for distribution of any-play voice, high speed Internet, Virtual Private Network (VPN) data, Ethernet Line (ELINE), Ethernet LAN (ELAN), video services (IPTV), Rural Broadband, and Mobile Datacom applications. Fully compliant with IEEE 1588V2 Precision Time Protocol standard for base station timing and synchronization, the product line supports both legacy TDM circuit-switched transport through pseudo-wire emulation and next-generation packet-switched transport through native Ethernet over SynchE and additionally provides assured availability with GPON’s optional network protection switching mechanisms.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.